|
DDX3X expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.711600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.772000E-01 |
| Normal-vs-Stage2 |
3.249400E-01 |
| Normal-vs-Stage3 |
7.498000E-02 |
| Normal-vs-Stage4 |
4.068000E-02 |
| Stage1-vs-Stage2 |
1.890180E-01 |
| Stage1-vs-Stage3 |
1.577980E-02 |
| Stage1-vs-Stage4 |
1.058250E-02 |
| Stage2-vs-Stage3 |
7.019800E-01 |
| Stage2-vs-Stage4 |
5.028600E-01 |
| Stage3-vs-Stage4 |
6.699400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.947200E-01 |
| Normal-vs-AfricanAmerican |
2.246200E-01 |
| Normal-vs-Asian |
9.094200E-01 |
| Caucasian-vs-AfricanAmerican |
5.963000E-01 |
| Caucasian-vs-Asian |
6.866600E-01 |
| AfricanAmerican-vs-Asian |
5.178000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22609999999124E-05 |
| Normal-vs-Female |
3.042300E-04 |
| Male-vs-Female |
1.62447832963153E-12 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.471560E-02 |
| Normal-vs-Age(41-60Yrs) |
2.946800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.251200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.233400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.096350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.348100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.409600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.953600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.511400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.773200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.145850E-01 |
| Normal-vs-Grade 2 |
4.295400E-01 |
| Normal-vs-Grade 3 |
2.712300E-02 |
| Normal-vs-Grade 4 |
1.221600E-03 |
| Grade 1-vs-Grade 2 |
8.412100E-02 |
| Grade 1-vs-Grade 3 |
2.787600E-02 |
| Grade 1-vs-Grade 4 |
1.174330E-02 |
| Grade 2-vs-Grade 3 |
1.237870E-04 |
| Grade 2-vs-Grade 4 |
4.07680000003019E-06 |
| Grade 3-vs-Grade 4 |
1.610020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.641600E-02 |
| Normal-vs-ccB subtype |
2.937200E-03 |
| ccA subtype-vs-ccB subtype |
8.15059997272272E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.929000E-01 |
| Normal-vs-N1 |
2.843600E-02 |
| N0-vs-N1 |
1.024160E-01 |
|
|
